Fat Loss Peptides in India

India's most effective research-grade fat loss peptides, all independently HPLC-verified to 99%+ purity. From the triple-agonist Reta to the mitochondrial activator MOTS-C — every compound ships with a Certificate of Analysis.

Order on WhatsApp

Available Fat Loss Peptides in India

Reta
₹3,799 / 10mg
Triple agonist (GIP/GLP-1/glucagon). Clinical trials show 17–24% body weight reduction. Most potent fat loss peptide available.
View Product
Tirzepatide
₹3,999 / 20mg
Dual GIP/GLP-1 receptor agonist. Clinically proven for weight management and metabolic research.
View Product
MOTS-C
₹2,999 / 10mg
Mitochondrial-derived peptide activating AMPK, enhancing insulin sensitivity and metabolic flexibility.
View Product
AOD-9604
₹3,499 / 5mg
HGH fragment 177-191. Activates fat-burning lipolysis pathways without growth-promoting side effects.
View Product

Why Choose Peptide Central?

99% PurityEvery batch independently HPLC and mass spectrometry verified.
COA With Every OrderCertificate of Analysis ships with your package.
COD AvailablePay on delivery across all of India. No upfront risk.
WhatsApp SupportExpert guidance 7 days a week via WhatsApp.
Cold-Chain ShippingTemperature-controlled packaging for full potency.
Pan-India DeliveryDiscreet delivery in 3–5 business days nationwide.

How to Order

1. Click Order on WhatsApp above.

2. Tell us which peptide, quantity, and your delivery address.

3. We confirm stock and send you payment/COD options.

4. Your order is dispatched within 24 hours with tracking.

Order on WhatsApp

Choosing a Fat Loss Peptide in India

The fat loss peptides researched most heavily in India fall into two groups. Incretin agonists — Reta (a GIP/GLP-1/glucagon triple agonist) and Tirzepatide (a dual GIP/GLP-1 agonist) — act on appetite and glucose-regulation pathways and show the largest body-weight reductions in published clinical trials. Metabolic peptides — MOTS-C and AOD-9604 — target mitochondrial function and lipolysis rather than appetite, and are studied for their effect on energy metabolism without incretin-related side effects.

For research planning, the practical differences are dosing frequency and half-life. Reta and Tirzepatide are long-acting (roughly weekly protocols in the literature), while AOD-9604 has a very short half-life and is studied at daily frequencies. Every vial we ship is HPLC- and mass-spectrometry-verified to ≥98% purity with a batch-specific Certificate of Analysis, so the compound in the vial matches the label — the single most important variable when comparing fat loss peptide suppliers in India.

All fat loss peptides sold here are for laboratory and analytical research use only and are not approved for human consumption in India.

Related Guides